These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Lemmens K, Doggen K, De Keulenaer GW. Circulation; 2007 Aug 21; 116(8):954-60. PubMed ID: 17709650 [Abstract] [Full Text] [Related]
6. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. Doggen K, Ray L, Mathieu M, Mc Entee K, Lemmens K, De Keulenaer GW. J Mol Cell Cardiol; 2009 Jan 21; 46(1):33-8. PubMed ID: 19010331 [Abstract] [Full Text] [Related]
7. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, Minatoguchi S, Fujiwara T, Fujiwara H. Circulation; 2006 Jan 31; 113(4):535-43. PubMed ID: 16449733 [Abstract] [Full Text] [Related]
11. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Gu X, Liu X, Xu D, Li X, Yan M, Qi Y, Yan W, Wang W, Pan J, Xu Y, Xi B, Cheng L, Jia J, Wang K, Ge J, Zhou M. Cardiovasc Res; 2010 Nov 01; 88(2):334-43. PubMed ID: 20615916 [Abstract] [Full Text] [Related]
12. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury. Gabrielson K, Bedja D, Pin S, Tsao A, Gama L, Yuan B, Muratore N. Cancer Res; 2007 Feb 15; 67(4):1436-41. PubMed ID: 17308081 [Abstract] [Full Text] [Related]
15. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk. Vandekerckhove L, Vermeulen Z, Liu ZZ, Boimvaser S, Patzak A, Segers VF, De Keulenaer GW. Am J Physiol Endocrinol Metab; 2016 Apr 01; 310(7):E495-504. PubMed ID: 26786778 [Abstract] [Full Text] [Related]
16. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats. Palaniyandi SS, Nagai Y, Watanabe K, Ma M, Veeraveedu PT, Prakash P, Kamal FA, Abe Y, Yamaguchi K, Tachikawa H, Kodama M, Aizawa Y. Exp Biol Med (Maywood); 2007 Oct 01; 232(9):1213-21. PubMed ID: 17895529 [Abstract] [Full Text] [Related]
19. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster. Serose A, Prudhon B, Salmon A, Doyennette MA, Fiszman MY, Fromes Y. Basic Res Cardiol; 2005 Mar 01; 100(2):161-70. PubMed ID: 15611844 [Abstract] [Full Text] [Related]